Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > NGL loving buying at these prices
View:
Post by Inthepez on Oct 07, 2022 12:09pm

NGL loving buying at these prices

before news hits next week. Definitely better than buying at 62 ;) . It will great by EOY lol!
Comment by davgro on Oct 07, 2022 12:32pm
Considering we are in a bear market with an impending recession now inevitable, ATE's stock price  has held up quite well.  There is a lot of blood in the water especially in biotech and healthcare stocks so I have no complaints with the low ATE trading volume, minimal price movements or lack of news.  But then again I'm not flipping pennies for lunch money. " ...more  
Comment by MrMugsy on Oct 07, 2022 2:41pm
Agreed Boys - great price considering there's just no demand at the moment. Without demand, there's no market - and - without a market, you won't see a fair valuation. Best to steal the shares from the scared ... as we've been doing. That's the way I see it - anyway. There should be lots of fence-sitting money right now, trying to figure out where to put their cash. If we can ...more  
Comment by Duster340 on Oct 09, 2022 10:11am
what in the world is this guy talking about ate has not held up quite well only 3 cents off a 52 week low, not unlike one of the worst performing sectors  the canadian cannabis industry,  which most companies also are at or near 52 week lows. what color is the sky in davgro's world, he is totally out of touch with reality again.
Comment by Banana1234 on Oct 12, 2022 10:18am
What's your prediction for EOY price?
Comment by davgro on Oct 12, 2022 10:44am
I think EOY stock price for ATE will depend on several factors: General market conditions.  If market continues to drift lower it is envitable that ATE will follow suit with weak hands and low volume. Year-end tax loss selling could also push the stock price lower. Will results of any animal studies on the drug new formulation be released before year-end, and if so, will ...more  
Comment by Duster340 on Oct 12, 2022 1:59pm
Once again davgro makes a useless atempt of an analysis. haha this guy is never right, my advice  maybe leave it to the pros.
Comment by Inthepez on Oct 12, 2022 11:55am
I think scraping the molar trial is being interpreted incorrectly so it changes my EOY prediction. Otherwise I would've guessed 0.80+ Nature of biotech is rapid change based on evolving data. Idk if you realize that banana, but if you can't wait, I suggest you bounce  i
Comment by StockingUp21 on Oct 13, 2022 12:52pm
tired of being dunk on he blocks everyone and dunks himself lmao   
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities